Major advantages of personalized medicine according to pharma companies 2015
This statistic is based on a survey conducted during the 2nd quarter of 2015. It describes major advantages of developing personalized medicines according to pharmaceutical companies in Asia, Europe, and in the United States. Some 26 percent of respondents stated that the likelihood of a higher drug price tag would be a major advantage of personalized medicines.